5-MeO-DiPT

From Food & Medicine Encyclopedia

5-MeO-DiPT


5-MeO-DiPT (5-Methoxy-N,N-diisopropyltryptamine) is a psychedelic and hallucinogenic drug, used recreationally for its psychoactive effects. It is part of the tryptamine class of drugs, which also includes substances like psilocybin, found in magic mushrooms, and DMT.

History[edit]

5-MeO-DiPT was first synthesized in 1979 by the chemist Alexander Shulgin, who documented his findings in the book TiHKAL (Tryptamines I Have Known and Loved). The drug gained popularity in the late 1990s and early 2000s as a legal alternative to other psychedelic substances.

Pharmacology[edit]

5-MeO-DiPT acts primarily as a serotonin receptor agonist. It binds to and activates the receptor, leading to an increased release of serotonin in the brain. This increase in serotonin levels is thought to be responsible for the drug's psychedelic effects.

Effects[edit]

The effects of 5-MeO-DiPT are similar to those of other tryptamines and can include visual and auditory hallucinations, altered perception of time, enhanced introspection, and increased emotional sensitivity. However, 5-MeO-DiPT is also known for its unique entactogenic effects, which can include feelings of empathy and emotional openness.

Legal Status[edit]

The legal status of 5-MeO-DiPT varies by country. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act, meaning it is illegal to manufacture, distribute, or possess. In the United Kingdom, it is classified as a Class A drug under the Misuse of Drugs Act.

See Also[edit]



Psychoactive drugs
Stimulants
Depressants
Hallucinogens
Cannabis
Dissociatives
This psychoactive drug related article is a stub.




Hallucinogens

Types

Related topics

This hallucinogen related article is a stub.



Tryptamine and related compounds
Substances
Research
Health and Safety
Legal Status
Culture and Society
This tryptamine related article is a stub.




Serotonin receptor agonists
[[5-HT1 receptor]] agonists
* [[5-HT1A receptor agonist|5-HT1A]]
  • [[5-HT1B receptor agonist|5-HT1B]]
  • [[5-HT1D receptor agonist|5-HT1D]]
  • [[5-HT1E receptor agonist|5-HT1E]]
  • [[5-HT1F receptor agonist|5-HT1F]]
[[5-HT2 receptor]] agonists
* [[5-HT2A receptor agonist|5-HT2A]]
  • [[5-HT2B receptor agonist|5-HT2B]]
  • [[5-HT2C receptor agonist|5-HT2C]]
[[5-HT3 receptor]] agonists
* [[5-HT3 receptor agonist]]
[[5-HT4 receptor]] agonists
* [[5-HT4 receptor agonist]]
[[5-HT5 receptor]] agonists
* [[5-HT5A receptor agonist|5-HT5A]]
  • [[5-HT5B receptor agonist|5-HT5B (not present in humans)]]
This Serotonin receptor agonist related article is a stub.




Schedule I drugs
Opioids
Stimulants
Hallucinogens
Cannabinoids
Dissociatives
This Schedule I drug related article is a stub.


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=5-MeO-DiPT&oldid=5368251"